88970 <common-name>N-(4,5-dihydro-5-oxo-1-phenyl-1H-pyrazol-3-yl)-N2-(2-methylpropionyl)-N2-octadecyl-L-asparagine</common-name> <description>N-(4,5-dihydro-5-oxo-1-phenyl-1H-pyrazol-3-yl)-N2-(2-methylpropionyl)-N2-octadecyl-L-asparagine belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 612.86 g/mol, N-(4,5-dihydro-5-oxo-1-phenyl-1H-pyrazol-3-yl)-N2-(2-methylpropionyl)-N2-octadecyl-L-asparagine is a heavy molecule. Its chemical formula is C35H56N4O5.</description> <cas nil="true"/> <pubchem-id>21116505</pubchem-id> <chemical-formula>C35H56N4O5</chemical-formula> <weight nil="true"/> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-04-04T23:27:04Z</created-at> <updated-at type="dateTime">2026-04-04T23:27:04Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCCCCCCCCCCCCCCCN(C(CC(=O)N=C1CC(=O)N(N1)C1=CC=CC=C1)C(O)=O)C(=O)C(C)C</moldb-smiles> <moldb-formula>C35H56N4O5</moldb-formula> <moldb-inchi>InChI=1/C35H56N4O5/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-22-25-38(34(42)28(2)3)30(35(43)44)26-32(40)36-31-27-33(41)39(37-31)29-23-20-19-21-24-29/h19-21,23-24,28,30H,4-18,22,25-27H2,1-3H3,(H,43,44)(H,36,37,40)</moldb-inchi> <moldb-inchikey>JLUISDDIQNPTPU-PMERELPUSA-N</moldb-inchikey> <moldb-average-mass type="decimal">612.856</moldb-average-mass> <moldb-mono-mass type="decimal">612.4250709</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp nil="true"/> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM084863</chemdb-id> <dsstox-id>DTXSID20944073</dsstox-id> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id>NS00049793</susdat-id> <iupac nil="true"/> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer">0</paper-count> <sync-id>CED0136644</sync-id> <structure-inchikey>JLUISDDIQNPTPU-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000402000000000200800000000000000000000000000000000000000000000000001002000020000000000000000004000000000000000008000000000000000000000080000040010000000000008020000000000000000004000000014000000022010000400000000000004000000000020500000000000000000000000000004040000000800000200001010000000000000100000020000000000000002400000000040004000000080000000000000008000000000000400000002000000008000000001000000000000000040000800000000000000200000000000000000040000820040040000000012400000001000000000000000001000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAsAAAALQAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAA AAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIG AGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBwAoAAAA AwMGAGAAAAADAQYAYAAAAAICBgAoAAAAAwQIACgAAAADAgcAKAAAAAMDBgAo AAAAAwQGAGAAAAACAgYAKAAAAAMECAAoAAAAAwIHACgAAAADAwcAaAAAAAMC AQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAAAwMB BkBoAAAAAwMBBgAoAAAAAwQIAGgAAAADAQEIACgAAAADAgYAKAAAAAMECAAo AAAAAwIGAGAAAAADAQYAYAAAAAEDBgBgAAAAAQMLAAEAAQIAAgMAAwQABAUA BQYABgcABwgACAkACQoACgsACwwADA0ADQ4ADg8ADxAAEBEAERIAEhMAExQA FBUAFRYoAhUXIBcYKAIYGQAZGgAaGygCGhwgHB0AHB4gHh9oDB8gaAwgIWgM ISJoDCIjaAwTJAAkJSAkJigCEicgJygoAicpACkqACkrAB0YICMeaAxCAgAA AAUYGRocHQYfICEiIx4XBAAAAAAAAAAW </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T04:32:26Z</structure-indexed-at> </compound>